Major Depressive Disorder and Bipolar Disorder Predispose Youth to Accelerated Atherosclerosis and Early Cardiovascular Disease: A Scientific Statement From the American Heart Association

In the 2011 “Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents,” several medical conditions among youth were identified that predispose to accelerated atherosclerosis and early cardiovascular disease (CVD), and risk stratification and management strategies for youth with these conditions were elaborated. Major depressive disorder (MDD) and bipolar disorder (BD) among youth satisfy the criteria set for, and therefore merit inclusion among, Expert Panel tier II moderate-risk conditions. The combined prevalence of MDD and BD among adolescents in the United States is ≈10%, at least 10 times greater than the prevalence of the existing moderate-risk conditions combined. The high prevalence of MDD and BD underscores the importance of positioning these diseases alongside other pediatric diseases previously identified as moderate risk for CVD. The overall objective of this statement is to increase awareness and recognition of MDD and BD among youth as moderate-risk conditions for early CVD. To achieve this objective, the primary specific aims of this statement are to (1) summarize evidence that MDD and BD are tier II moderate-risk conditions associated with accelerated atherosclerosis and early CVD and (2) position MDD and BD as tier II moderate-risk conditions that require the application of risk stratification and management strategies in accordance with Expert Panel recommendations. In this scientific statement, there is an integration of the various factors that putatively underlie the association of MDD and BD with CVD, including pathophysiological mechanisms, traditional CVD risk factors, behavioral and environmental factors, and psychiatric medications.

[1]  R. Lam,et al.  Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. , 2009, The international journal of neuropsychopharmacology.

[2]  R. Dantzer,et al.  Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy , 2001, Psychoneuroendocrinology.

[3]  C. Correll Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: a systematic review and pooled analysis of short-term trials. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[4]  A. Dunn,et al.  Molecular Mechanisms of Actions of Interleukin-6 on the Brain, with Special Reference to Serotonin and the Hypothalamo-Pituitary-Adrenocortical Axis , 1999, Neurochemical Research.

[5]  V. Meyer-Rochow,et al.  Insulin Resistance and Depressive Symptoms in Young Adult Males: Findings From Finnish Military Conscripts , 2007, Psychosomatic medicine.

[6]  R. Post,et al.  Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. , 2008, Revista brasileira de psiquiatria.

[7]  J. Danesh,et al.  C‐reactive protein and coronary heart disease: a critical review , 2008, Journal of internal medicine.

[8]  B. Grant,et al.  Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. , 2005, The Journal of clinical psychiatry.

[9]  R. Badenhop,et al.  A smoking–dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene , 1996, Nature Medicine.

[10]  T. Muto,et al.  Presence of an interaction between smoking and being overweight increases risks of hypertension, diabetes, and cardiovascular disease in outpatients with mood disorders , 2012, Environmental Health and Preventive Medicine.

[11]  N. Frasure-smith,et al.  Reflections on Depression as a Cardiac Risk Factor , 2005, Psychosomatic medicine.

[12]  Peter Bennett,et al.  The metabolic syndrome in children and adolescents – an IDF consensus report , 2007, Pediatric diabetes.

[13]  R. Olvera,et al.  Medical comorbidity among youth diagnosed with bipolar disorder in the United States. , 2009, The Journal of clinical psychiatry.

[14]  G. Miller,et al.  Acute deviations from long-term trait depressive symptoms predict systemic inflammatory activity , 2008, Brain, Behavior, and Immunity.

[15]  M. Garg,et al.  Reduced mania and depression in juvenile bipolar disorder associated with long-chain ω-3 polyunsaturated fatty acid supplementation , 2009, European Journal of Clinical Nutrition.

[16]  R. S. Smith The macrophage theory of depression. , 1991, Medical hypotheses.

[17]  Andrew H. Miller,et al.  Cytokines sing the blues: inflammation and the pathogenesis of depression. , 2006, Trends in immunology.

[18]  H. Seo,et al.  Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials. , 2012, Archives of internal medicine.

[19]  T. Dinan,et al.  Antidepressant therapy and C-reactive protein levels , 2006, British Journal of Psychiatry.

[20]  C. Correll Elevated cardiovascular risk in patients with bipolar disorder: when does it start and where does it lead? , 2008, The Journal of clinical psychiatry.

[21]  J. Cai,et al.  Association of cardiac autonomic function and the development of hypertension: the ARIC study. , 1996, American journal of hypertension.

[22]  Desmond E. Williams,et al.  Prevalence and Correlates of Depressed Mood Among Youth With Diabetes: The SEARCH for Diabetes in Youth Study , 2006, Pediatrics.

[23]  Francesca Bosetti,et al.  Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder? , 2002, Archives of general psychiatry.

[24]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[25]  A. Douaihy,et al.  A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report. , 2011, Journal of child and adolescent psychopharmacology.

[26]  Ngianga-Bakwin Kandala,et al.  Meta-analysis of short sleep duration and obesity in children and adults. , 2008, Sleep.

[27]  J. Biederman,et al.  Is bipolar disorder a risk for cigarette smoking in ADHD youth? , 2000, The American journal on addictions.

[28]  A. Folsom,et al.  Prospective Investigation of Autonomic Nervous System Function and the Development of Type 2 Diabetes: The Atherosclerosis Risk In Communities Study, 1987–1998 , 2003, Circulation.

[29]  B. Goldstein Recent progress in understanding pediatric bipolar disorder. , 2012, Archives of pediatrics & adolescent medicine.

[30]  J. Fiedorowicz,et al.  Mania and mortality: Why the excess cardiovascular risk in bipolar disorder? , 2009, Current psychiatry reports.

[31]  Tara Gomes,et al.  Risk of incident diabetes among patients treated with statins: population based study , 2013, BMJ.

[32]  Richie Poulton,et al.  Childhood maltreatment predicts adult inflammation in a life-course study , 2007, Proceedings of the National Academy of Sciences.

[33]  Jagmeet P. Singh,et al.  Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. , 1998, Hypertension.

[34]  J. Ballenger The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments , 2011 .

[35]  M. Tsuang,et al.  Causes of Death in Schizophrenia and Manic-Depression , 1980, British Journal of Psychiatry.

[36]  J. O'Loughlin,et al.  Depressive Symptoms and C-Reactive Protein Are Not Associated in a Population-Based Sample of Adolescents , 2010, International journal of behavioral medicine.

[37]  G. Dibona The sympathetic nervous system and hypertension: recent developments. , 2004, Hypertension.

[38]  K. Matthews,et al.  Sleep duration and insulin resistance in healthy black and white adolescents. , 2012, Sleep.

[39]  P. Sienaert,et al.  Metabolic syndrome and metabolic abnormalities in bipolar disorder: a meta-analysis of prevalence rates and moderators. , 2013, The American journal of psychiatry.

[40]  A. Danese,et al.  Childhood maltreatment and obesity: systematic review and meta-analysis , 2014, Molecular Psychiatry.

[41]  D. Simons-Morton,et al.  Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2011, Pediatrics.

[42]  B. Goldstein,et al.  Childhood onset major depressive disorder: course of illness and psychiatric comorbidity in a community sample. , 2009, The Journal of pediatrics.

[43]  C. Mathers,et al.  Global burden of disease in young people aged 10–24 years: a systematic analysis , 2011, The Lancet.

[44]  K. Merikangas,et al.  Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication--Adolescent Supplement (NCS-A). , 2010, Journal of the American Academy of Child and Adolescent Psychiatry.

[45]  D. Jacobs,et al.  Influence of autonomic nervous system dysfunction on the development of type 2 diabetes: the CARDIA study. , 2003, Diabetes care.

[46]  K. Matthews,et al.  Depressive symptoms and subclinical markers of cardiovascular disease in adolescents. , 2011, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[47]  Pasquale Strazzullo,et al.  Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. , 2011, European heart journal.

[48]  A. Nierenberg,et al.  Long-Term implications of early onset in bipolar disorder: data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD) , 2004, Biological Psychiatry.

[49]  C. Fitzpatrick,et al.  Depression in adolescence. , 1995, Irish medical journal.

[50]  A. Merikangas,et al.  The association between major depressive disorder and obesity in US adolescents: results from the 2001–2004 National Health and Nutrition Examination Survey , 2012, Journal of Behavioral Medicine.

[51]  Masao Yoshizumi,et al.  Endothelial function and oxidative stress in cardiovascular diseases. , 2009, Circulation journal : official journal of the Japanese Circulation Society.

[52]  B. Penninx,et al.  Longitudinal Evidence for Unfavorable Effects of Antidepressants on Heart Rate Variability , 2010, Biological Psychiatry.

[53]  G. Canino,et al.  Psychiatric Disorders Associated with Substance Use Among Children and Adolescents: Findings from the Methods for the Epidemiology of Child and Adolescent Mental Disorders (MECA) Study , 1997, Journal of abnormal child psychology.

[54]  Manuel A. R. Ferreira,et al.  Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder , 2008, Nature Genetics.

[55]  I. Hickie,et al.  Short sleep duration in prevalent and persistent psychological distress in young adults: the DRIVE study. , 2010, Sleep.

[56]  C. Correll Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[57]  C. Nemeroff,et al.  Epidemiology of comorbid coronary artery disease and depression , 2003, Biological Psychiatry.

[58]  J. Viikari,et al.  Depressive symptoms and the metabolic syndrome in childhood and adulthood: a prospective cohort study. , 2009, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[59]  R. Salomon,et al.  Increased oxidative stress in patients with depression and its relationship to treatment , 2013, Psychiatry Research.

[60]  M. DelBello,et al.  Long-term safety of divalproex sodium extended-release in children and adolescents with bipolar I disorder. , 2009, Journal of child and adolescent psychopharmacology.

[61]  Jitender Sareen,et al.  The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders. , 2012, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[62]  P. Währborg,et al.  Anger, depression and anxiety associated with endothelial function in childhood and adolescence , 2009, Archives of Disease in Childhood.

[63]  S. Daniels,et al.  Metabolic and Inflammatory Links to Depression in Youth With Diabetes , 2012, Diabetes Care.

[64]  C. Levenson,et al.  Role of zinc in the development and treatment of mood disorders , 2010, Current opinion in clinical nutrition and metabolic care.

[65]  M. Vinberg,et al.  Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis. , 2013, Journal of psychiatric research.

[66]  I. Hickie,et al.  Manipulating the sleep-wake cycle and circadian rhythms to improve clinical management of major depression , 2013, BMC Medicine.

[67]  N. Ryan,et al.  Preliminary findings regarding overweight and obesity in pediatric bipolar disorder. , 2008, The Journal of clinical psychiatry.

[68]  R. Belmaker,et al.  Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. , 2006, The American journal of psychiatry.

[69]  J. Vincent,et al.  A multi-tissue analysis identifies HLA complex group 9 gene methylation differences in bipolar disorder , 2012, Molecular Psychiatry.

[70]  R. Shelton,et al.  Oxidative stress and glutathione response in tissue cultures from persons with major depression. , 2012, Journal of psychiatric research.

[71]  J Licinio,et al.  Polymorphisms in inflammation-related genes are associated with susceptibility to major depression and antidepressant response , 2008, Molecular Psychiatry.

[72]  Dante Cicchetti,et al.  Child maltreatment. , 2005, Annual review of clinical psychology.

[73]  R. McIntyre,et al.  Metabolic and cardiovascular adverse events associated with antipsychotic treatment in children and adolescents. , 2008, Archives of pediatrics & adolescent medicine.

[74]  R. Kessler,et al.  Childhood adversities and first onset of psychiatric disorders in a national sample of US adolescents. , 2012, Archives of general psychiatry.

[75]  N. Ryan,et al.  The bidirectional relationship between body mass index and treatment outcome in adolescents with treatment-resistant depression. , 2013, Journal of child and adolescent psychopharmacology.

[76]  K. Fletcher,et al.  Screening for childhood trauma in adult primary care patients: a cross-sectional survey. , 2010, Primary care companion to the Journal of clinical psychiatry.

[77]  David Finkelhor,et al.  Violence, crime, and abuse exposure in a national sample of children and youth: an update. , 2013, JAMA pediatrics.

[78]  K. Matthews,et al.  Childhood physical abuse is associated with incident metabolic syndrome in mid-life women. , 2013, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[79]  G. Parker,et al.  ‘D’ for depression: any role for vitamin D? , 2011, Acta psychiatrica Scandinavica.

[80]  Rongwei Fu,et al.  C-Reactive Protein as a Risk Factor for Coronary Heart Disease: A Systematic Review and Meta-analyses for the U.S. Preventive Services Task Force , 2009, Annals of Internal Medicine.

[81]  H. Bogner,et al.  Integrated Management of Type 2 Diabetes Mellitus and Depression Treatment to Improve Medication Adherence: A Randomized Controlled Trial , 2012, The Annals of Family Medicine.

[82]  James A. Blumenthal,et al.  Depression, Heart Rate Variability, and Acute Myocardial Infarction , 2001, Circulation.

[83]  R. McIntyre,et al.  The risk of developing type 2 diabetes mellitus associated with psychotropic drug use in children and adolescents: a retrospective cohort analysis. , 2012, The Primary Care Companion For CNS Disorders.

[84]  R. Mojtabai Antidepressant use and glycemic control , 2013, Psychopharmacology.

[85]  Do Peterson,et al.  Collaborative care for patients with depression and chronic illnesses. , 2010, The New England journal of medicine.

[86]  L. Smeeth,et al.  The association between antipsychotic agents and the risk of myocardial infarction: a systematic review , 2011, British journal of clinical pharmacology.

[87]  Ganesh Dakhale,et al.  Oxidative Damage and Schizophrenia: The Potential Benefit by Atypical Antipsychotics , 2004, Neuropsychobiology.

[88]  R. McIntyre,et al.  Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent‐onset bipolar disorder , 2011, Human psychopharmacology.

[89]  Shih-Yi Huang,et al.  A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Patients with Depression , 2010, Biological Psychiatry.

[90]  T. Meinertz,et al.  Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease , 2001, Circulation.

[91]  K. Markides,et al.  Depression predicts increased incidence of adverse health outcomes in older Mexican Americans with type 2 diabetes. , 2003, Diabetes care.

[92]  C. Nemeroff,et al.  The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. , 1998, Archives of general psychiatry.

[93]  C. Nemeroff,et al.  The link between childhood trauma and depression: Insights from HPA axis studies in humans , 2008, Psychoneuroendocrinology.

[94]  D. Ramsdale,et al.  Smoking and coronary artery disease assessed by routine coronary arteriography. , 1985, British medical journal.

[95]  R. Clouse,et al.  Recent advances in understanding depression in adults with diabetes , 2007, Current diabetes reports.

[96]  M. Irwin Psychoneuroimmunology of Depression: Clinical Implications , 2002, Brain, Behavior, and Immunity.

[97]  R. Armitage,et al.  Sex and age differences in sleep macroarchitecture in childhood and adolescent depression. , 2006, Sleep.

[98]  David Brent,et al.  Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[99]  J. Biederman,et al.  Omega-3 fatty acid monotherapy for pediatric bipolar disorder: A prospective open-label trial , 2007, European Neuropsychopharmacology.

[100]  R. McIntyre,et al.  A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder. , 2010, The Journal of clinical psychiatry.

[101]  N. Wray,et al.  Research review: the role of cytokines in depression in adolescents: a systematic review. , 2013, Journal of child psychology and psychiatry, and allied disciplines.

[102]  D. Chapman,et al.  Insights Into Causal Pathways for Ischemic Heart Disease: Adverse Childhood Experiences Study , 2004, Circulation.

[103]  Satoshi Sasaki,et al.  Fish and n-3 Polyunsaturated Fatty Acid Intake and Depressive Symptoms: Ryukyus Child Health Study , 2010, Pediatrics.

[104]  Duanping Liao,et al.  Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the atherosclerosis risk in communities (ARIC) study. , 2002, Diabetes.

[105]  A. Harvey,et al.  Sleep and circadian rhythms in children and adolescents with bipolar disorder , 2006, Development and Psychopathology.

[106]  K. Kendler,et al.  Toward a Comprehensive Developmental Model for Major Depression in Women , 2002 .

[107]  G. Miller,et al.  Multiwave Associations Between Depressive Symptoms and Endothelial Function in Adolescent and Young Adult Females , 2011, Psychosomatic medicine.

[108]  Rita A. Longaker,et al.  Exercise tolerance is reduced in bipolar illness. , 2007, Journal of affective disorders.

[109]  J. Ballenger A Randomized Controlled Trial of Risperidone, Lithium, or Divalproex Sodium for Initial Treatment of Bipolar I Disorder, Manic or Mixed Phase, in Children and Adolescents , 2013 .

[110]  R. McIntyre,et al.  Inflammation and the phenomenology, pathophysiology, comorbidity, and treatment of bipolar disorder: a systematic review of the literature. , 2009, The Journal of clinical psychiatry.

[111]  P. Jensen,et al.  Guidelines for Adolescent Depression in Primary Care (GLAD-PC): I. Identification, Assessment, and Initial Management , 2007, Pediatrics.

[112]  Peter J. Schwartz,et al.  Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias Implications for Clinical Trials , 2001 .

[113]  M. Carter Diagnostic and Statistical Manual of Mental Disorders, 5th ed. , 2014 .

[114]  S. Daniels,et al.  Use of the metabolic syndrome in pediatrics: a blessing and a curse. , 2009, Seminars in pediatric surgery.

[115]  L. Alfredsson,et al.  Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden , 2013, BMJ Open.

[116]  M. Dubé,et al.  Genetic predictors of depressive symptoms in cardiac patients , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[117]  P. López-Jaramillo,et al.  Plasma Nitrate Levels and Flow-Mediated Vasodilation in Untreated Major Depression , 2011, Psychosomatic medicine.

[118]  S. Szanton,et al.  Depression and Oxidative Stress: Results From a Meta-Analysis of Observational Studies , 2014, Psychosomatic medicine.

[119]  M. Berk,et al.  A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[120]  J. Markowitz,et al.  Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response. , 1999, Journal of affective disorders.

[121]  M. Fava,et al.  Preadult onset vs. adult onset of major depressive disorder: a replication study , 2007, Acta psychiatrica Scandinavica.

[122]  R. McIntyre,et al.  Bipolar disorder and metabolic syndrome: an international perspective. , 2010, Journal of affective disorders.

[123]  Martin P Paulus,et al.  Heart rate variability in bipolar mania and schizophrenia. , 2010, Journal of psychiatric research.

[124]  M. DelBello,et al.  Antipsychotic and mood stabilizer efficacy and tolerability in pediatric and adult patients with bipolar I mania: a comparative analysis of acute, randomized, placebo-controlled trials. , 2010, Bipolar disorders.

[125]  D. Levy,et al.  Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. , 1996, Circulation.

[126]  D. Clark,et al.  Major depression associated with earlier alcohol relapse in treated teens with AUD. , 2004, Addictive behaviors.

[127]  Chris Parker,et al.  Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. , 2007, Archives of general psychiatry.

[128]  Barbara Napolitano,et al.  Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. , 2009, JAMA.

[129]  N. Allen,et al.  Autonomic cardiac control in depressed adolescents , 2010, Depression and anxiety.

[130]  G. Högberg,et al.  Depressed adolescents in a case‐series were low in vitamin D and depression was ameliorated by vitamin D supplementation , 2012, Acta paediatrica.

[131]  B. Goldstein,et al.  Pharmacologic treatment of bipolar disorder in children and adolescents. , 2012, Child and adolescent psychiatric clinics of North America.

[132]  D. F. Drake,et al.  A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. , 2013, JAMA psychiatry.

[133]  I. Ferrier,et al.  The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. , 2009, Bipolar disorders.

[134]  F. Zitman,et al.  Association between major depressive disorder and heart rate variability in the Netherlands Study of Depression and Anxiety (NESDA). , 2008, Archives of general psychiatry.

[135]  C. Blanco,et al.  The burden of obesity among adults with bipolar disorder in the United States , 2011, Bipolar disorders.

[136]  Sidney C. Smith,et al.  MARKERS OF INFLAMMATION AND CARDIOVASCULAR DISEASE: APPLICATION TO CLINICAL AND PUBLIC HEALTH PRACTICE: A STATEMENT FOR HEALTHCARE PROFESSIONALS FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION AND THE AMERICAN HEART ASSOCIATION , 2003 .

[137]  J. Rice,et al.  Manic/Hypomanic Symptom Burden and Cardiovascular Mortality in Bipolar Disorder , 2009, Psychosomatic medicine.

[138]  N. Ryan,et al.  Significance of cigarette smoking among youths with bipolar disorder. , 2008, The American journal on addictions.

[139]  Mark Olfson,et al.  Service utilization for lifetime mental disorders in U.S. adolescents: results of the National Comorbidity Survey-Adolescent Supplement (NCS-A). , 2011, Journal of the American Academy of Child and Adolescent Psychiatry.

[140]  J. Viikari,et al.  Depressive Symptoms and Carotid Artery Intima-Media Thickness in Young Adults: The Cardiovascular Risk in Young Finns Study , 2005, Psychosomatic medicine.

[141]  S Woolhandler,et al.  Smoking and mental illness: A population-based prevalence study. , 2000, JAMA.

[142]  C. Lyketsos,et al.  Examining a bidirectional association between depressive symptoms and diabetes. , 2008, JAMA.

[143]  C. Enger,et al.  Risk of developing diabetes and dyslipidemia among adolescents with bipolar disorder or schizophrenia , 2013, International journal of adolescent medicine and health.

[144]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[145]  S. Selek,et al.  Changes in nitric oxide level and superoxide dismutase activity during antimanic treatment , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[146]  T. Suppes,et al.  The poor prognosis of childhood-onset bipolar disorder. , 2007, The Journal of pediatrics.

[147]  M. Alda,et al.  Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. , 1995, Journal of affective disorders.

[148]  M. Hori,et al.  PE-050 Neointimal Hyperplasia was Greater between 3 and 8 Months Follow-up after Sirolimus-eluting Stent Implantation in Small Vessels with Calcified Lesions(PE009,Coronary Revascularization, PCI (DES) 2 (IHD),Poster Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation So , 2009 .

[149]  J. Gorman,et al.  Heart rate variability in depressive and anxiety disorders. , 2000, American heart journal.

[150]  Yogesh K. Dwivedi,et al.  Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. , 2010, Journal of affective disorders.

[151]  Roberto Elosua,et al.  A gain-of-function SNP in TRPC4 cation channel protects against myocardial infarction. , 2011, Cardiovascular research.

[152]  B. Birmaher,et al.  Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. , 2011, Journal of child and adolescent psychopharmacology.

[153]  U. P. S. T. Force Screening and Treatment for Major Depressive Disorder in Children and Adolescents: US Preventive Services Task Force Recommendation Statement , 2009, Pediatrics.

[154]  R. Carney,et al.  The Association Between Major Depressive Disorder in Childhood and Risk Factors for Cardiovascular Disease in Adolescence , 2014, Psychosomatic medicine.

[155]  P. Gean,et al.  The change of insulin levels after six weeks antidepressant use in drug-naïve major depressive patients. , 2013, Journal of affective disorders.

[156]  A. Harvey,et al.  The complex role of sleep in adolescent depression. , 2012, Child and adolescent psychiatric clinics of North America.

[157]  R. Rugulies Depression as a predictor for coronary heart disease. a review and meta-analysis. , 2002, American journal of preventive medicine.

[158]  O. Almeida,et al.  Depression and smoking amongst older general practice patients. , 2005, Journal of affective disorders.

[159]  H. Sies Oxidative stress: from basic research to clinical application. , 1991, The American journal of medicine.

[160]  Amit J. Shah,et al.  Depression and history of attempted suicide as risk factors for heart disease mortality in young individuals. , 2011, Archives of general psychiatry.

[161]  M. Vinberg,et al.  Cytokines in bipolar disorder: a systematic review and meta-analysis. , 2013, Journal of affective disorders.

[162]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[163]  Rosalind J Wright,et al.  Physical and Sexual Abuse in Childhood as Predictors of Early-Onset Cardiovascular Events in Women , 2012, Circulation.

[164]  M. Höfler,et al.  Physical activity and prevalence and incidence of mental disorders in adolescents and young adults , 2007, Psychological Medicine.

[165]  X. Zhang,et al.  The Effect of Risperidone Treatment on Superoxide Dismutase in Schizophrenia , 2003, Journal of clinical psychopharmacology.

[166]  A. Quyyumi,et al.  Major depression and coronary flow reserve detected by positron emission tomography. , 2009, Archives of internal medicine.

[167]  Viola Vaccarino,et al.  Depression as a Risk Factor for Poor Prognosis Among Patients With Acute Coronary Syndrome: Systematic Review and Recommendations A Scientific Statement From the American Heart Association , 2014, Circulation.

[168]  K. Felmingham,et al.  Impact of Depression and Antidepressant Treatment on Heart Rate Variability: A Review and Meta-Analysis , 2010, Biological Psychiatry.

[169]  Michelle Shardell,et al.  Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. , 2010, The Journal of clinical endocrinology and metabolism.

[170]  K. Su,et al.  A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. , 2007, The Journal of clinical psychiatry.

[171]  Jeannie-Marie S. Leoutsakos,et al.  History of manic and hypomanic episodes and risk of incident cardiovascular disease: 11.5 year follow-up from the Baltimore Epidemiologic Catchment Area Study. , 2010, Journal of affective disorders.

[172]  O. Shirihai,et al.  Altered Mitochondrial Dynamics Contributes to Endothelial Dysfunction in Diabetes Mellitus , 2011, Circulation.

[173]  A. Reiff,et al.  Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. , 2000, The New England journal of medicine.

[174]  P. Jensen,et al.  Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and Ongoing Management , 2007, Pediatrics.

[175]  Nathan Clark Consensus development conference on antipsychotic drugs and obesity and diabetes. , 2004, The Journal of clinical psychiatry.

[176]  Benicio N Frey,et al.  Oxidative stress markers in bipolar disorder: a meta-analysis. , 2008, Journal of affective disorders.

[177]  S. Kennedy,et al.  The Association between Childhood Adversity and Components of Metabolic Syndrome in Adults with Mood Disorders: Results from the International Mood Disorders Collaborative Project , 2012, International journal of psychiatry in medicine.

[178]  C. Gottfried,et al.  Serum S100B and antioxidant enzymes in bipolar patients. , 2007, Journal of psychiatric research.

[179]  D. Martínez-Gómez,et al.  Sedentarismo, adiposidad y factores de riesgo cardiovascular en adolescentes. Estudio AFINOS , 2010 .

[180]  J. Thayer,et al.  Heart rate variability, overnight urinary norepinephrine, and plasma cholesterol in apparently healthy human adults. , 2013, International journal of cardiology.

[181]  K. Swedberg n-3 Fatty acids in cardiovascular disease. , 2011, The New England journal of medicine.

[182]  S. Rapoport,et al.  Increased excitotoxicity and neuroinflammatory markers in postmortem frontal cortex from bipolar disorder patients , 2010, Molecular Psychiatry.

[183]  S. Stewart,et al.  Depressive symptoms and smoking among Hong Kong Chinese adolescents. , 2005, Addiction.

[184]  R. McIntyre,et al.  The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. , 2012, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

[185]  R. Carney,et al.  Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. , 2009, JAMA.

[186]  G. Bernal,et al.  State of the science on psychosocial interventions for ethnic minorities. , 2005, Annual review of clinical psychology.

[187]  M. Garg,et al.  Long-Chain Omega-3 Polyunsaturated Fatty Acids in the Blood of Children and Adolescents with Juvenile Bipolar Disorder , 2008, Lipids.

[188]  D. Clark,et al.  Gender and comorbid psychopathology in adolescents with alcohol dependence. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[189]  V. Helgeson,et al.  Children with Diabetes Compared to Peers: Depressed? Distressed? , 2011, Annals of behavioral medicine : a publication of the Society of Behavioral Medicine.

[190]  P. Kris-Etherton,et al.  The role of diet and nutritional supplements in preventing and treating cardiovascular disease , 2009, Current opinion in cardiology.

[191]  G. Faulkner,et al.  Bipolar disorder and leisure-time physical activity: Results from a national survey of Canadians , 2009 .

[192]  R. Callaghan,et al.  The incidence of cardiovascular morbidity among patients with bipolar disorder: a population-based longitudinal study in Ontario, Canada. , 2010, Journal of affective disorders.

[193]  S. Rapoport,et al.  Chronic Administration of Lamotrigine Downregulates COX-2 mRNA and Protein in Rat Frontal Cortex , 2008, Neurochemical Research.

[194]  A. Mykletun,et al.  Diet quality in bipolar disorder in a population-based sample of women. , 2011, Journal of affective disorders.

[195]  R. McIntyre,et al.  Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap , 2009, Current diabetes reports.

[196]  N. Herrmann,et al.  A Meta-Analysis of Cytokines in Major Depression , 2010, Biological Psychiatry.

[197]  K. Juel,et al.  Cardiovascular death and manic-depressive psychosis. , 1987, Journal of affective disorders.

[198]  S. Gabriel,et al.  Whole-genome association study of bipolar disorder , 2008, Molecular Psychiatry.

[199]  J. Jerrell,et al.  Neurological and Cardiovascular Adverse Events Associated with Antimanic Treatment in Children and Adolescents , 2010, CNS neuroscience & therapeutics.

[200]  P. Ridker Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. , 2007, Nutrition reviews.

[201]  A Voss,et al.  Linear and nonlinear methods for analyses of cardiovascular variability in bipolar disorders. , 2006, Bipolar disorders.

[202]  W. Nolen,et al.  A discriminating messenger RNA signature for bipolar disorder formed by an aberrant expression of inflammatory genes in monocytes. , 2008, Archives of general psychiatry.

[203]  U. Förstermann,et al.  Simultaneous assessment of endothelial function, nitric oxide synthase activity, nitric oxide-mediated signaling, and oxidative stress in individuals with and without hypercholesterolemia. , 2008, Clinical chemistry.

[204]  W. Sadee,et al.  CACNA1C Gene Polymorphisms, Cardiovascular Disease Outcomes, and Treatment Response , 2009, Circulation. Cardiovascular genetics.

[205]  R. Kessler,et al.  Childhood adversities and adult psychiatric disorders in the national comorbidity survey replication I: associations with first onset of DSM-IV disorders. , 2010, Archives of general psychiatry.

[206]  J. Rabe-Jabłońska,et al.  [Affective disorders in the fourth edition of the classification of mental disorders prepared by the American Psychiatric Association -- diagnostic and statistical manual of mental disorders]. , 1993, Psychiatria polska.

[207]  A. Kilbourne,et al.  Nutrition and exercise behavior among patients with bipolar disorder. , 2007, Bipolar disorders.

[208]  A. Harvey The adverse consequences of sleep disturbance in pediatric bipolar disorder: implications for intervention. , 2009, Child and adolescent psychiatric clinics of North America.

[209]  S. Cole,et al.  Clustering of Depression and Inflammation in Adolescents Previously Exposed to Childhood Adversity , 2012, Biological Psychiatry.

[210]  J. Racoosin,et al.  Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statement. , 2004, Diabetes care.

[211]  Andrea L Dunn,et al.  Inverse association between physical inactivity and mental health in men and women. , 2006, Medicine and science in sports and exercise.

[212]  M. Rubenfire,et al.  Abnormal brachial artery flow-mediated vasodilation in young adults with major depression. , 2001, The American journal of cardiology.

[213]  Suzanne G. Leveille,et al.  Exploring the effect of depression on physical disability: longitudinal evidence from the established populations for epidemiologic studies of the elderly. , 1999, American journal of public health.

[214]  Daniel M. Hartung,et al.  Metabolic screening in children receiving antipsychotic drug treatment. , 2010, Archives of pediatrics & adolescent medicine.

[215]  J. McClellan,et al.  Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.

[216]  A L Dannenberg,et al.  Physical activity and depressive symptoms: the NHANES I Epidemiologic Follow-up Study. , 1988, American journal of epidemiology.

[217]  K. Brady,et al.  Cigarette smoking and psychiatric comorbidity in children and adolescents. , 2002, Journal of the American Academy of Child and Adolescent Psychiatry.

[218]  J. Hibbeln,et al.  Cross-national comparisons of seafood consumption and rates of bipolar disorders. , 2003, The American journal of psychiatry.

[219]  M. Ingvar,et al.  Pro-inflammatory cytokines are elevated in adolescent females with emotional disorders not treated with SSRIs. , 2012, Journal of affective disorders.

[220]  B. Goldstein,et al.  Further evidence for a developmental subtype of bipolar disorder defined by age at onset: results from the national epidemiologic survey on alcohol and related conditions. , 2006, The American journal of psychiatry.

[221]  B. Bondy,et al.  Major depressive disorder is associated with cardiovascular risk factors and low Omega-3 Index. , 2011, The Journal of clinical psychiatry.

[222]  Does the cardiac autonomic response to postural change predict incident coronary heart disease and mortality? The Atherosclerosis Risk in Communities Study. , 2002, American journal of epidemiology.

[223]  E. Brietzke,et al.  Cytokine Alterations in Bipolar Disorder: A Meta-Analysis of 30 Studies , 2013, Biological Psychiatry.

[224]  E. Costello,et al.  Cumulative Depression Episodes Predict Later C-Reactive Protein Levels: A Prospective Analysis , 2012, Biological Psychiatry.

[225]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[226]  J Thomas Bigger,et al.  Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdiscip , 2008, Circulation.

[227]  V. Parikh,et al.  Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[228]  M. Kandefer-Szerszeń,et al.  Accelerated apoptosis of blood leukocytes and oxidative stress in blood of patients with major depression , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[229]  David J Kupfer,et al.  Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. , 2009, Bipolar disorders.

[230]  Mark E Molitch,et al.  The association among autonomic nervous system function, incident diabetes, and intervention arm in the Diabetes Prevention Program. , 2006, Diabetes care.

[231]  J. Babb,et al.  Immune system dysregulation in adolescent major depressive disorder. , 2009, Journal of affective disorders.

[232]  M. Weissman,et al.  The association between childhood depression and adulthood body mass index. , 2001, Pediatrics.

[233]  P. Sparén,et al.  Excess mortality in bipolar and unipolar disorder in Sweden. , 2001, Archives of general psychiatry.

[234]  B. Druss,et al.  A randomized trial of medical care management for community mental health settings: the Primary Care Access, Referral, and Evaluation (PCARE) study. , 2010, The American journal of psychiatry.

[235]  J. Eisenmann,et al.  Sedentary behavior, adiposity and cardiovascular risk factors in adolescents. The AFINOS study. , 2010, Revista espanola de cardiologia.

[236]  M. Barclay,et al.  Manic-Depressive Insanity and Paranoia , 1921, The Indian Medical Gazette.

[237]  B. Birmaher,et al.  Treatment guidelines for children and adolescents with bipolar disorder. , 2005, Journal of the American Academy of Child and Adolescent Psychiatry.

[238]  Kenneth S Kendler,et al.  Toward a comprehensive developmental model for major depression in men. , 2006, The American journal of psychiatry.

[239]  A. Must,et al.  Adolescent Obesity and Risk for Subsequent Major Depressive Disorder and Anxiety Disorder: Prospective Evidence , 2007, Psychosomatic medicine.

[240]  O. Bukstein,et al.  Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention. , 2010, The Journal of clinical psychiatry.

[241]  D. Mischoulon,et al.  Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression. , 2012, The Journal of clinical psychiatry.

[242]  H. Critchley,et al.  Inflammation Causes Mood Changes Through Alterations in Subgenual Cingulate Activity and Mesolimbic Connectivity , 2009, Biological Psychiatry.

[243]  N. Herrmann,et al.  Zinc in Depression: A Meta-Analysis , 2013, Biological Psychiatry.

[244]  K. Chayama,et al.  Endothelial function and oxidative stress in renovascular hypertension. , 2002, The New England journal of medicine.

[245]  Cinnamon A. Stetler,et al.  A Meta-Analytic Review of the Effects of Childhood Abuse on Medical Outcomes in Adulthood , 2009, Psychosomatic medicine.

[246]  Jeffrey S. Gonzalez,et al.  A review of treating depression in diabetes: emerging findings. , 2011, Psychosomatics.

[247]  D. Todder,et al.  Nonlinear analysis of RR interval in euthymic bipolar disorder , 2005, Autonomic Neuroscience.

[248]  V. Meyer-Rochow,et al.  Depressive symptoms and insulin resistance in young adult males: results from the Northern Finland 1966 birth cohort , 2006, Molecular Psychiatry.

[249]  D. Cicchetti,et al.  Diverse patterns of neuroendocrine activity in maltreated children , 2001, Development and Psychopathology.

[250]  A. Lichtenstein Nutrient supplements and cardiovascular disease: a heartbreaking story Published, JLR Papers in Press, November 6, 2008. , 2009, Journal of Lipid Research.

[251]  Gary L Myers,et al.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. , 2003, Circulation.

[252]  D. James,et al.  Tobacco smoking behaviors in bipolar disorder: a comparison of the general population, schizophrenia, and major depression. , 2009, Bipolar disorders.

[253]  A K Manatunga,et al.  Paroxetine for the prevention of depression induced by high-dose interferon alfa. , 2001, The New England journal of medicine.

[254]  North American Association for the Study of Obesity , 1991, International journal of obesity.

[255]  J. Fiedorowicz,et al.  Vascular function is not impaired early in the course of bipolar disorder. , 2012, Journal of psychosomatic research.

[256]  G. Kenis,et al.  Effects of antidepressants on the production of cytokines. , 2002, The international journal of neuropsychopharmacology.

[257]  A. Caspi,et al.  Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers. , 2009, Archives of pediatrics & adolescent medicine.

[258]  A. Danese,et al.  Childhood maltreatment predicts unfavorable course of illness and treatment outcome in depression: a meta-analysis. , 2011, The American journal of psychiatry.

[259]  Charles L. Raison,et al.  Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression , 2009, Biological Psychiatry.

[260]  W. Brown,et al.  Comparative mortality risk in adult patients with schizophrenia, depression, bipolar disorder, anxiety disorders, and attention-deficit/hyperactivity disorder participating in psychopharmacology clinical trials. , 2013, JAMA psychiatry.

[261]  A. Kilbourne,et al.  Improving medical and psychiatric outcomes among individuals with bipolar disorder: a randomized controlled trial. , 2008, Psychiatric services.

[262]  D. Axelson,et al.  Early intervention for adolescents at high risk for the development of bipolar disorder: pilot study of Interpersonal and Social Rhythm Therapy (IPSRT). , 2014, Psychotherapy.

[263]  S. Sasaki,et al.  Dietary intake and depressive symptoms: a systematic review of observational studies. , 2010, Molecular nutrition & food research.

[264]  F. Dickerson,et al.  Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder , 2007, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[265]  A J Camm,et al.  Baroreflex Sensitivity and Heart Rate Variability in the Identification of Patients at Risk for Life-Threatening Arrhythmias: Implications for Clinical Trials , 2001, Circulation.

[266]  T. Su,et al.  Comorbidity of cardiovascular diseases with mood and anxiety disorder: A population based 4‐year study , 2009, Psychiatry and clinical neurosciences.

[267]  S. Strakowski,et al.  Body mass indexes and lipid profiles in hospitalized children and adolescents exposed to atypical antipsychotics. , 2007, Journal of child and adolescent psychopharmacology.

[268]  J. Biederman,et al.  Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[269]  S. Patten,et al.  Lifestyle Characteristics of Psychiatric Outpatients , 2008, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[270]  Rebecca Tillman,et al.  Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. , 2008, Archives of general psychiatry.

[271]  B. Vitiello,et al.  Pharmacotherapy of bipolar disorder in children and adolescents , 2006 .

[272]  R. Kessler,et al.  The identification and validation of distinct depressive syndromes in a population-based sample of female twins. , 1996, Archives of general psychiatry.

[273]  G. Miller,et al.  Where There Is Depression, There Is Inflammation․․․Sometimes! , 2007, Biological Psychiatry.

[274]  C. Correll Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescents. , 2008, The Journal of clinical psychiatry.

[275]  K. Torén,et al.  Cardiovascular fitness in males at age 18 and risk of serious depression in adulthood: Swedish prospective population-based study. , 2012, The British journal of psychiatry : the journal of mental science.

[276]  J. Newcomer,et al.  Prevalence and predictors of lipid and glucose monitoring in commercially insured patients treated with second-generation antipsychotic agents. , 2009, The American journal of psychiatry.

[277]  P. Cowen,et al.  Cardiovascular and metabolic risk profile in young people at familial risk of depression , 2013, British Journal of Psychiatry.